These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 20103675

  • 1. MiR-222 overexpression confers cell migratory advantages in hepatocellular carcinoma through enhancing AKT signaling.
    Wong QW, Ching AK, Chan AW, Choy KW, To KF, Lai PB, Wong N.
    Clin Cancer Res; 2010 Feb 01; 16(3):867-75. PubMed ID: 20103675
    [Abstract] [Full Text] [Related]

  • 2. MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1.
    Wong QW, Lung RW, Law PT, Lai PB, Chan KY, To KF, Wong N.
    Gastroenterology; 2008 Jul 01; 135(1):257-69. PubMed ID: 18555017
    [Abstract] [Full Text] [Related]

  • 3. MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells.
    Liu WH, Yeh SH, Lu CC, Yu SL, Chen HY, Lin CY, Chen DS, Chen PJ.
    Gastroenterology; 2009 Feb 01; 136(2):683-93. PubMed ID: 19027010
    [Abstract] [Full Text] [Related]

  • 4. MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells.
    Salvi A, Sabelli C, Moncini S, Venturin M, Arici B, Riva P, Portolani N, Giulini SM, De Petro G, Barlati S.
    FEBS J; 2009 Jun 01; 276(11):2966-82. PubMed ID: 19490101
    [Abstract] [Full Text] [Related]

  • 5. MiR-145 modulates multiple components of the insulin-like growth factor pathway in hepatocellular carcinoma.
    Law PT, Ching AK, Chan AW, Wong QW, Wong CK, To KF, Wong N.
    Carcinogenesis; 2012 Jun 01; 33(6):1134-41. PubMed ID: 22431718
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells.
    Fornari F, Gramantieri L, Giovannini C, Veronese A, Ferracin M, Sabbioni S, Calin GA, Grazi GL, Croce CM, Tavolari S, Chieco P, Negrini M, Bolondi L.
    Cancer Res; 2009 Jul 15; 69(14):5761-7. PubMed ID: 19584283
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Proteomic identification of microRNA-122a target proteins in hepatocellular carcinoma.
    Diao S, Zhang JF, Wang H, He ML, Lin MC, Chen Y, Kung HF.
    Proteomics; 2010 Oct 15; 10(20):3723-31. PubMed ID: 20859956
    [Abstract] [Full Text] [Related]

  • 12. Comprehensive analysis of microRNA-regulated protein interaction network reveals the tumor suppressive role of microRNA-149 in human hepatocellular carcinoma via targeting AKT-mTOR pathway.
    Zhang Y, Guo X, Xiong L, Yu L, Li Z, Guo Q, Li Z, Li B, Lin N.
    Mol Cancer; 2014 Nov 26; 13():253. PubMed ID: 25424347
    [Abstract] [Full Text] [Related]

  • 13. MicroRNA-145 suppresses hepatocellular carcinoma by targeting IRS1 and its downstream Akt signaling.
    Wang Y, Hu C, Cheng J, Chen B, Ke Q, Lv Z, Wu J, Zhou Y.
    Biochem Biophys Res Commun; 2014 Apr 18; 446(4):1255-60. PubMed ID: 24690171
    [Abstract] [Full Text] [Related]

  • 14. miR-198 inhibits migration and invasion of hepatocellular carcinoma cells by targeting the HGF/c-MET pathway.
    Tan S, Li R, Ding K, Lobie PE, Zhu T.
    FEBS Lett; 2011 Jul 21; 585(14):2229-34. PubMed ID: 21658389
    [Abstract] [Full Text] [Related]

  • 15. Lentivirus-mediated overexpression of microRNA-199a inhibits cell proliferation of human hepatocellular carcinoma.
    Jia XQ, Cheng HQ, Qian X, Bian CX, Shi ZM, Zhang JP, Jiang BH, Feng ZQ.
    Cell Biochem Biophys; 2012 Jan 21; 62(1):237-44. PubMed ID: 21847633
    [Abstract] [Full Text] [Related]

  • 16. miR-122 targets an anti-apoptotic gene, Bcl-w, in human hepatocellular carcinoma cell lines.
    Lin CJ, Gong HY, Tseng HC, Wang WL, Wu JL.
    Biochem Biophys Res Commun; 2008 Oct 24; 375(3):315-20. PubMed ID: 18692484
    [Abstract] [Full Text] [Related]

  • 17. miR-222 overexpression may contribute to liver fibrosis in biliary atresia by targeting PPP2R2A.
    Dong R, Zheng Y, Chen G, Zhao R, Zhou Z, Zheng S.
    J Pediatr Gastroenterol Nutr; 2015 Jan 24; 60(1):84-90. PubMed ID: 25238119
    [Abstract] [Full Text] [Related]

  • 18. Transcriptional regulation of miR-224 upregulated in human HCCs by NFκB inflammatory pathways.
    Scisciani C, Vossio S, Guerrieri F, Schinzari V, De Iaco R, D'Onorio de Meo P, Cervello M, Montalto G, Pollicino T, Raimondo G, Levrero M, Pediconi N.
    J Hepatol; 2012 Apr 24; 56(4):855-61. PubMed ID: 22178270
    [Abstract] [Full Text] [Related]

  • 19. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
    Dong-Dong L, Xi-Ran Z.
    Hepatogastroenterology; 2004 Apr 24; 51(56):515-25. PubMed ID: 15086194
    [Abstract] [Full Text] [Related]

  • 20. The impact of miR-34a on protein output in hepatocellular carcinoma HepG2 cells.
    Cheng J, Zhou L, Xie QF, Xie HY, Wei XY, Gao F, Xing CY, Xu X, Li LJ, Zheng SS.
    Proteomics; 2010 Apr 24; 10(8):1557-72. PubMed ID: 20186752
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.